[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 5, 2014

Addressing Prescription Opioid OverdoseData Support a Comprehensive Policy Approach

Author Affiliations
  • 1Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland
  • 2Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
JAMA. 2014;312(17):1733-1734. doi:10.1001/jama.2014.13480

Preventing prescription opioid overdose deaths is a public health priority. Deaths from these medications exceed deaths from all illicit drugs combined.1 News reports, actions by states, and congressional legislation that single out the recently approved extended-release hydrocodone product Zohydro ER raise critical questions about the most effective policy needed to reverse the problem.

First Page Preview View Large
First page PDF preview
First page PDF preview